The Molecular Basis of Partial Reversal or Significant Slowing of ALS, Parkinson’s Disease, and Lewy Body Dementia by Mesenchymal Exosomes/Secretome

医学 肌萎缩侧索硬化 鼻腔给药 不利影响 疾病 间充质干细胞 路易体 痴呆 内科学 中枢神经系统 治疗效果 多发性硬化 病理 路易氏体型失智症 进行性疾病 肿瘤科 退行性疾病 中枢神经系统疾病 临床疗效 临床病理学 阿尔茨海默病 退行性疾病
作者
Chadwick C. Prodromos,Ruby Del Villar,Andrew Striegel,Gerard Rufí Pena,Rohan Dixit
出处
期刊:International Journal of Molecular Sciences [Multidisciplinary Digital Publishing Institute]
卷期号:27 (10): 4483-4483 被引量:4
标识
DOI:10.3390/ijms27104483
摘要

Neuromuscular and neurodegenerative (NMND) disorders are diseases that cause progressive damage to the central nervous system leaving patients with symptoms that negatively affect everyday living with death almost inevitable. These include amyotrophic lateral sclerosis (ALS), Lewy body dementia (LBD), and Parkinson's disease (PD) with cases expected to increase in the future. Intranasally administered stem cell-derived exosomes/secretome have been seen as potential therapeutic options for these disorders in preclinical animal models. This study sought to observe the efficacy of mesenchymal stem cell-derived exosomes/secretome in patients with ALS, LBD, and PD. Based off these preclinical studies, we conducted a case-controlled series experiment with 86 patients with ALS, LBD, or PD, with the independent variable being the treatment and the dependent variable being the clinical response. These patients were recruited and given intranasal instillations of various MSC-derived exosome/secretome products. Subsequent treatments were given to patients who did not have a response to one product. Patients were followed up at one week, one, two, three, and six months post-treatment. Historical external controls were used for comparison to clinical outcomes. There were no serious adverse events in any patient. A total of 67 of 86 (77%) patients showed a positive clinical response to at least one product. Outcomes were strongly associated with greater treatment frequency for ALS and LBD. Intranasal administration of MSC-derived exosome/secretome products were safe, and most patients showed overall improvement with at least one product. Some patients also saw a substantial decrease in the rate of decline compared to historical controls. These results also give rise to the hypothesis: do MSC-derived exosomes/secretome treatments show efficacy in other NMND disorders? The primary limitation of this study is the 6-month follow-up.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
nan完成签到,获得积分10
2秒前
大佬完成签到,获得积分10
3秒前
3秒前
4秒前
4秒前
共享精神的应助被云隐采纳,获得10
5秒前
^O^完成签到,获得积分10
5秒前
Aegleseeker完成签到,获得积分10
6秒前
咻咻完成签到,获得积分10
7秒前
我我我发布了新的文献求助10
7秒前
依然完成签到,获得积分10
8秒前
8秒前
qzh006完成签到,获得积分10
8秒前
8秒前
小蘑菇的应助被geat采纳,获得10
8秒前
淡然雅寒完成签到 ,获得积分10
9秒前
9秒前
烟花的应助被暴龙战士采纳,获得10
9秒前
春桑早点睡完成签到,获得积分10
10秒前
桐桐的应助被墨洋采纳,获得10
10秒前
10秒前
MMLi发布了新的文献求助10
10秒前
俊逸的又琴完成签到 ,获得积分10
10秒前
CipherSage的应助被赫江涛采纳,获得10
11秒前
jessie完成签到,获得积分20
11秒前
11秒前
兴奋的凤发布了新的文献求助20
11秒前
11秒前
聪慧含芙发布了新的文献求助10
12秒前
冷艳小蚂蚁完成签到,获得积分10
12秒前
12秒前
爆米花的应助被saturnring采纳,获得10
13秒前
大模型的应助被仙女不喝酒采纳,获得10
13秒前
春衫完成签到,获得积分10
14秒前
染染完成签到 ,获得积分10
14秒前
16秒前
17秒前
仰望星空完成签到,获得积分10
18秒前
19秒前
别构调节关注了科研通微信公众号
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193514
求助须知:如何正确求助?哪些是违规求助? 9579686
关于积分的说明 21866883
捐赠科研通 7793152
什么是DOI,文献DOI怎么找? 3437297
关于科研通互助平台的介绍 2560725
邀请新用户注册赠送积分活动 2484176